Prevention of anthracycline-induced cardiotoxicity in children: The evidence-Reference-Cited by-同舟云学术

Prevention of anthracycline-induced cardiotoxicity in children: The evidence

Published:2007-05 Issue:7 Volume:43 Page:1134-1140
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Dalen Elvira C.,Caron Huib N.,Kremer Leontien C.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Childhood cancer survival in Europe and the United States;Gatta;Cancer,2002

2. Heikens J. Childhood cancer and the price of cure: studies on late effects of childhood cancer treatment. Thesis. Amsterdam: University of Amsterdam; 2000.

3. Risk factors for doxorubicin-induced congestive heart failure;Von Hoff;Ann Intern Med,1979

4. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia;Lipshultz;J Clin Oncol,2005

5. Anthracycline-induced cardiotoxicity;Shan;Ann Intern Med,1996

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis;Complementary Therapies in Medicine;2024-08

2. A quantitative systems pharmacology approach to predict the safe‐equivalent dose of doxorubicin in patients with cardiovascular comorbidity;CPT: Pharmacometrics & Systems Pharmacology;2021-10-13

3. Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age;Hematology Reports;2021-03-05

4. Anthracycline-induced cardiotoxicity: Is there a role for myocardial 123I-mIBG scintigraphy?;Journal of Nuclear Cardiology;2019-01-02

5. Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor;Chinese Medical Journal;2018-06-20